Trevi Therapeutics
TRVI
#6350
Rank
HK$4.54 B
Marketcap
HK$47.03
Share price
-2.73%
Change (1 day)
93.18%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -HK$2.43

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2.41. In 2022 the company made an earnings per share (EPS) of -HK$4.35 an increase over its 2021 EPS that were of -HK$11.66.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$2.43-44.17%
2022-HK$4.35-62.67%
2021-HK$11.66-17.29%
2020-HK$14.1018.17%
2019-HK$11.93-46.21%
2018-HK$22.18